From lab coat to deal sheet: celebrating Michael Kakanis’ journey to Director

17.9.2024

We’re thrilled to announce the promotion of Michael Kakanis to Director at InterFinancial and his recent appointment as Co-Chair of Healthcare at Clairfield International.

Michael’s journey is nothing short of inspiring. Working as a lecturer in Physiology and Biochemistry while completing his PhD in Immunology, Michael was all set for a long career in Academia. But in 2017, he took a leap of faith and left behind a promising career in science to explore the dynamic financial industry. Along with a CFA Level 1 under his belt, Michael was determined to get his foot in the door.

After countless coffee catch-ups and a fair share of setbacks, Michael’s persistence paid off when our Executive Chair, Sharon Doyle offered him a 10-day internship. This opportunity quickly translated into a part-time analyst position, and from there, Michael’s career path took off.

Since then, Michael has been lucky to work across various sectors, both on the buy-side and sell-side, including financial services, defence, IT services & software, professional & engineering services, mining technology & services. However, it is in the health services and technology space that Michael has truly found his niche. His expertise in M&A over the years has seen him drive some key deals at InterFinancial, such as:

Alliance Automation: Michael achieved an exceptional outcome for the client while navigating the challenges of the COVID-19 pandemic.

National Veterinary Care: Michael’s first public-to-private deal saw him deliver outstanding results while collaborating with a fantastic team.

Microba: A cross-border buy-side deal with a strong scientific core in a rapidly emerging field, a space where Michael’s passion lies.

Please join us once again to congratulate Michael on his well-deserved promotion and recognition. We are proud to have him on the team and represent us on a global stage at Clairfield International. He’s truly an inspiration to all of us at InterFinancial!

29.5.2026

Tick tock – Why private business owners with less than 4 year exit horizons should reassess timing now

There was plenty of market chatter prior to the budget speech this year. Investors and asset owners were nervous. We had a client pushing for a deal to be signed before Budget Day. We managed to get this done, just in time. Several others in the business ecosystem spent the Mother’s Day weekend scrambling to […]

29.5.2026

Sector dashboards May 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

28.5.2026

InterFinancial advises Commit Works on sale to Datamine

Commit Works is a Brisbane-based software company serving the mining and metals industry. Its CiteOps platform digitises shift-level planning, resource allocation, task coordination and production tracking, connecting the short-term plan to what actually happens on shift across underground coal, open cut, underground hardrock and smelter operations globally. Datamine is the world’s leading provider of technology […]

29.4.2026

Sector dashboards April 2026

29.4.2026

From technical capability to economic inevitability: Why Clean Energy companies fail to scale?

Working with organisations attempting to commercialise clean energy technologies, I have observed a pattern persistent enough to warrant explicit articulation. Across hydrogen, electrification, storage, biogas, low-carbon fuels, and industrial heat, companies with credible technology, capable teams, and supportive boards still fail to compound enterprise value. Not because the technology disappoints, and not because the market […]

31.3.2026

Sector dashboards March 2026

31.3.2026

Not every healthcare deal is a sale: rethinking what M&A can look like

When healthcare business owners come to us thinking about a transaction, the conversation almost always starts in the same place. What is the business worth, and what does a sale process look like? Those are the right questions. But they’re not always the only ones that matter. Embedded in both is an assumption; that the […]

27.2.2026

Sector dashboards February 2026

27.2.2026

On the floor at EvokeAg 2026: Luke Harwood’s reflections on Australian Agtech

EvokeAg 2026 drew over 1,500 delegates from 18 countries to Melbourne in February, with the Federal Government committing another $450,000 to support the event over the next three years. The visible momentum is real, and the cohort of companies I spent two days meeting reflected it. Most were past proof-of-concept by a meaningful margin, with […]